Equities research analysts expect HCA Healthcare Inc (NYSE:HCA) to announce $12.16 billion in sales for the current quarter, Zacks Investment Research reports. Ten analysts have issued estimates for HCA Healthcare’s earnings, with the highest sales estimate coming in at $12.35 billion and the lowest estimate coming in at $12.04 billion. HCA Healthcare reported sales of $11.56 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 5.2%. The company is scheduled to announce its next earnings results on Tuesday, January 29th.
According to Zacks, analysts expect that HCA Healthcare will report full year sales of $46.53 billion for the current financial year, with estimates ranging from $46.20 billion to $46.76 billion. For the next fiscal year, analysts anticipate that the business will report sales of $49.52 billion, with estimates ranging from $48.59 billion to $50.67 billion. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for HCA Healthcare.
HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The business had revenue of $11.45 billion for the quarter, compared to analyst estimates of $11.29 billion. During the same period in the prior year, the firm posted $1.13 EPS. The company’s revenue was up 7.1% on a year-over-year basis.
HCA stock traded down $4.99 during mid-day trading on Wednesday, reaching $135.86. The company had a trading volume of 1,801,284 shares, compared to its average volume of 1,788,475. The stock has a market capitalization of $48.48 billion, a price-to-earnings ratio of 20.62, a PEG ratio of 1.24 and a beta of 0.52. HCA Healthcare has a one year low of $84.13 and a one year high of $147.42.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 28th. Shareholders of record on Monday, December 3rd will be paid a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date of this dividend is Friday, November 30th. HCA Healthcare’s dividend payout ratio is 21.24%.
In other HCA Healthcare news, SVP Deborah M. Reiner sold 723 shares of HCA Healthcare stock in a transaction that occurred on Monday, November 5th. The shares were sold at an average price of $135.06, for a total value of $97,648.38. Following the completion of the sale, the senior vice president now owns 6,184 shares of the company’s stock, valued at approximately $835,211.04. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Kathryn A. Torres sold 820 shares of HCA Healthcare stock in a transaction on Tuesday, November 13th. The stock was sold at an average price of $142.36, for a total transaction of $116,735.20. Following the transaction, the senior vice president now owns 4,237 shares in the company, valued at approximately $603,179.32. The disclosure for this sale can be found here. Insiders have sold 16,763 shares of company stock valued at $2,346,147 in the last three months. 2.80% of the stock is owned by insiders.
Hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. boosted its position in HCA Healthcare by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 19,916,360 shares of the company’s stock valued at $2,770,765,000 after buying an additional 66,808 shares during the period. FMR LLC increased its stake in HCA Healthcare by 98.7% during the 3rd quarter. FMR LLC now owns 10,907,407 shares of the company’s stock valued at $1,517,438,000 after purchasing an additional 5,419,134 shares in the last quarter. LSV Asset Management increased its stake in shares of HCA Healthcare by 0.3% in the third quarter. LSV Asset Management now owns 5,474,392 shares of the company’s stock worth $761,597,000 after acquiring an additional 15,004 shares during the period. Lyrical Asset Management LP increased its stake in shares of HCA Healthcare by 2.0% in the third quarter. Lyrical Asset Management LP now owns 4,078,212 shares of the company’s stock worth $567,361,000 after acquiring an additional 80,081 shares during the period. Finally, Northern Trust Corp grew its position in HCA Healthcare by 4.2% during the second quarter. Northern Trust Corp now owns 3,460,267 shares of the company’s stock valued at $355,023,000 after buying an additional 138,135 shares during the period. Institutional investors and hedge funds own 69.94% of the company’s stock.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
See Also: Derivative
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.